halcinonide
Selected indexed studies
- Halcinonide activates smoothened to ameliorate ischemic stroke injury. (Life Sci, 2025) [PMID:39710062]
- Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque Psoriasis. (J Drugs Dermatol, 2023) [PMID:37556520]
- Demonstration of the biphasic release of 0.1% halcinonide cream. (J Drugs Dermatol, 2015) [PMID:25607913]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Halcinonide activates smoothened to ameliorate ischemic stroke injury. (2025) pubmed
- Tildrakizumab in Combination With Topical Halcinonide 0.1% Ointment for Treating Moderate to Severe Plaque Psoriasis. (2023) pubmed
- Demonstration of the biphasic release of 0.1% halcinonide cream. (2015) pubmed
- Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies. (1977) pubmed
- Therapeutic uses of halcinonide. (1977) pubmed
- Identification and structural characterization of major stress degradation products of halcinonide by liquid chromatography-high-resolution mass spectrometry. (2023) pubmed
- Double-blind paired comparison clinical trial of halcinonide and hydrocortisone. (1978) pubmed
- A comparative study of amcinonide and halcinonide in the treatment of eczematous dermatitis. (1984) pubmed
- Effectiveness and Patient Acceptance of Halcinonide 0.1% Cream in 216g Jars for Large-area Steroid-responsive Dermatoses. (2011) pubmed
- Double-blind comparison of halcinonide solution and placebo control in treatment of psoriasis of the scalp. (1978) pubmed